Status:
UNKNOWN
Zolpidem on CPAP Acclimatization in OSA
Lead Sponsor:
Siriraj Hospital
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Obstructive sleep apnea (OSA) is a sleep disorder characterized by a cessation or significant decrease in airflow during sleep. CPAP is the preferred therapy and has high effectiveness at all levels o...
Detailed Description
Obstructive sleep apnea (OSA) is a sleep disorder characterized by a cessation or significant decrease in airflow during sleep. According to a recent study, OSA may impact over 1 billion individuals w...
Eligibility Criteria
Inclusion
- OSA patients whose sleep test demonstrated apnea-hypopnea index (AHI) ≥ 15 /hour or AHI ≥ 5 /hour with comorbid disease including hypertension, cardiovascular disease, and stroke
- Age 18 to 75 years
- Indicated for CPAP therapy
- Naïve for the device usage
Exclusion
- A history of zolpidem allergies
- Currently take hypnotic medications
- Denied permission to engage in the study and/or follow its protocol
- Individuals with liver diseases, including hepatitis from any cause, liver cirrhosis, and liver cancer
Key Trial Info
Start Date :
October 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06084130
Start Date
October 15 2023
End Date
October 15 2024
Last Update
October 16 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.